摘要
目的评价哌拉西林/他唑巴坦(特治星)治疗外科手术后腹腔感染的有效性及安全性。方法对术后140例腹腔感染患者经验性采用哌拉西林/他唑巴坦抗感染治疗。结果治疗总有效率为90.6%,细菌清除率89.8%,不良反应率3.6%。结论哌拉西林/他唑巴坦治疗术后腹腔感染效果良好,具有高效、安全、低毒特点。
OBJECTIVE To evaluate the efficacy and safety of piperacillin/tazobactam in the treatment of postoperative abdominal infection. METHODS Totally 140 patients with postoperative abdominal infection were empirically treated by piperacillin/tazobactam as anti-totally inflammatory therapy. RESULTS The total effective rate was 90.6%, the bacteria eradication rate was 89. 9%, the rate of adverse reactions occurring was 3. 6%.CONCLUSIONS Piperacillin/tazobactam is a highly effective, safe and low toxic agent in the treatment of postoperative abdominal infection.
出处
《中华医院感染学杂志》
CAS
CSCD
北大核心
2005年第8期937-938,共2页
Chinese Journal of Nosocomiology
关键词
哌拉西林/他唑巴坦
术后腹腔感染
Piperacillin/tazobactam, Postoperative abdominal infection